ReviewOncoTargets and therapy2023

Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab.

Nathan El-Ghazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.